Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Prostate Cancer

  Free Subscription


Articles published in Prog Urol

Retrieve available abstracts of 27 articles:
HTML format
Text format



Single Articles


    November 2018
  1. ROZET F, Hennequin C, Beauval JB, Beuzeboc P, et al
    [French ccAFU guidelines - Update 2018-2020: Prostate cancer].
    Prog Urol. 2018 Nov 1. pii: S1166-7087(18)30514.
    PubMed     Text format     Abstract available


    October 2018
  2. PATARD PM, Roumiguie M, Prudhomme T, Doumerc N, et al
    Migration in last decade to high-risk prostate cancer after radical prostatectomy.
    Prog Urol. 2018 Oct 15. pii: S1166-7087(18)30557.
    PubMed     Text format     Abstract available


    September 2018
  3. DELPORTE G, Henon F, Ploussard G, Briganti A, et al
    Radical prostatectomy for locally advanced and high-risk prostate cancer: A systematic review of the literature.
    Prog Urol. 2018 Sep 24. pii: S1166-7087(18)30472.
    PubMed     Text format     Abstract available


  4. AOUN F, Slaoui A, Walid EHO, Albisinni S, et al
    Association between phosphodiesterase type 5 inhibitors and prostate cancer: A systematic review.
    Prog Urol. 2018 Sep 7. pii: S1166-7087(18)30182.
    PubMed     Text format     Abstract available


    May 2018
  5. RAICHI A, Marcq G, Fantoni JC, Puech P, et al
    [Active surveillance in prostate cancer: Assessment of MRI in the selection and follow-up of patients].
    Prog Urol. 2018 May 31. pii: S1166-7087(18)30085.
    PubMed     Text format     Abstract available


  6. HACHI K, Boualga K, Chettibi K, Harouni M, et al
    [Study of the beneficial effects of triptorelin on lower urinary tract symptoms in Algeria in patients with non-localized prostate cancer].
    Prog Urol. 2018 May 20. pii: S1166-7087(18)30094.
    PubMed     Text format     Abstract available


  7. MARTIN-MALBURET A, Marcq G, Leroy X, Guiffart P, et al
    [Pathology findings after radical prostatectomy for prostate cancer in patients eligible for active surveillance: Contribution of multiparametric MRI to treatment decision].
    Prog Urol. 2018 May 20. pii: S1166-7087(18)30092.
    PubMed     Text format     Abstract available


    April 2018
  8. ROZET F, Hennequin C, Mongiat-Artus P, Beuzeboc P, et al
    [French CCAFU guidelines on prostate cancer: hormono-naive metastatic prostate cancer - update 2017].
    Prog Urol. 2018 Apr 18. pii: S1166-7087(18)30080.
    PubMed     Text format    


    March 2018
  9. GEVORGYAN A, Hetet JF, Robert M, Duchattelle-Dussaule V, et al
    [Salvage cryotherapy of prostate cancer after failed external radiotherapy and brachytherapy: Morbidity and mid-term oncological results].
    Prog Urol. 2018 Mar 15. pii: S1166-7087(17)30543.
    PubMed     Text format     Abstract available


    February 2018
  10. SARRADIN M, Lepiney C, Celhay O, Delpech PO, et al
    [Estimating minimum period of time to perform prostate MRI after prostate biopsy: Clinical and histological bleeding risk factors; from a prospective study].
    Prog Urol. 2018;28:85-93.
    PubMed     Text format     Abstract available


    January 2018
  11. ALBISINNI S, Aoun F, Noel A, El Rassy E, et al
    Are concurrent systematic cores needed at the time of targeted biopsy in patients with prior negative prostate biopsies?
    Prog Urol. 2018;28:18-24.
    PubMed     Text format     Abstract available


    December 2017
  12. DE LA TAILLE A, Mardoyan S, Lafaye A
    [Psychological impact of prostate cancer on patients receiving a 6-month androgen deprivation therapy].
    Prog Urol. 2017 Dec 6. pii: S1166-7087(17)30625.
    PubMed     Text format     Abstract available


  13. DE VERGIE S, Gaschignard N, Baron M, Branchereau J, et al
    [Long-term outcomes of prostate cancer patients with lymph nodes metastasis after radical prostatectomy and pelvic lymph node dissection].
    Prog Urol. 2017 Dec 5. pii: S1166-7087(17)30624.
    PubMed     Text format     Abstract available


    November 2017
  14. DEFONTAINES J, Salomon L, Champy C, Cholley I, et al
    [Prostate cancer diagnostic by saturation randomized biopsy versus rigid targeted biopsy].
    Prog Urol. 2017 Nov 6. pii: S1166-7087(17)30536.
    PubMed     Text format     Abstract available


    September 2017
  15. RENARD-PENNA R, Sanchez-Salas R, Barret E, Cosset JM, et al
    [Evaluation and results of ablative therapies in prostate cancer].
    Prog Urol. 2017 Sep 19. pii: S1166-7087(17)30455.
    PubMed     Text format     Abstract available


  16. BARRET E, Sanchez-Salas R, Galiano M, Cathala N, et al
    [Management of ablative therapies in prostate cancer].
    Prog Urol. 2017 Sep 14. pii: S1166-7087(17)30411.
    PubMed     Text format     Abstract available


  17. SANCHEZ-SALAS R, Barret E, Renard-Penna R, Cosset JM, et al
    [Indications and limits of ablative therapies in prostate cancer].
    Prog Urol. 2017 Sep 14. pii: S1166-7087(17)30456.
    PubMed     Text format     Abstract available


    June 2017
  18. MARIEN A, De Castro Abreu A, Gill I, Villers A, et al
    [Interest using 3D ultrasound and MRI fusion biopsy for prostate cancer detection].
    Prog Urol. 2017 Jun 16. pii: S1166-7087(17)30130.
    PubMed     Text format     Abstract available


    May 2017
  19. VIDMAR R, Marcq G, Flamand V, Fantoni JC, et al
    [Salvage radical prostatectomy for recurrent prostate cancer. Morbidity, oncological and functional results].
    Prog Urol. 2017 May 30. pii: S1166-7087(17)30108.
    PubMed     Text format     Abstract available


  20. GIRIER D, Chevrot A, Costa P, Thuret R, et al
    [Sexual consequences after treatment of prostate cancer: Inquiry among members of the Association Nationale des Malades du Cancer de la Prostate].
    Prog Urol. 2017 May 5. pii: S1166-7087(17)30075.
    PubMed     Text format     Abstract available


    April 2017
  21. MONDET F, Alimi JC, Boyer C
    [Cancer plans apply to surgical treatment of prostate cancer: A geographically isolated center balance].
    Prog Urol. 2017 Apr 6. pii: S1166-7087(17)30046.
    PubMed     Text format     Abstract available


  22. ROZET F, Roupret M, Hennequin C, Massard C, et al
    [Management of a progressing prostate cancer: results of a national study].
    Prog Urol. 2017 Apr 6. pii: S1166-7087(17)30022.
    PubMed     Text format     Abstract available


    March 2017
  23. LONG JA, Poinas G, Fiard G, Lepretre M, et al
    [Robot assisted radical prostatectomy: What are the evidences at the time of a specific funding?]
    Prog Urol. 2017;27:146-157.
    PubMed     Text format     Abstract available


  24. LIMANI K, Albisinni S, Aoun F, Le Dinh D, et al
    [Quality of life after robotic prostatectomy: Impact of BMI and age on urinary incontinence].
    Prog Urol. 2017;27:244-252.
    PubMed     Text format     Abstract available


    November 2016
  25. COHEN J, Andre C, Mozer P
    [Targeted MRI prostate biopsies].
    Prog Urol. 2016;26:854-859.
    PubMed     Text format     Abstract available


    July 2016
  26. RIOUX-LECLERCQ N, Comperat E, Kammerer-Jacquet SF, Camparo P, et al
    [Pathological advances in renal, prostatic, bladder and testis neoplasia].
    Prog Urol. 2016 Jul 26. pii: S1166-7087(16)30070.
    PubMed     Text format     Abstract available


    May 2016
  27. BARRE C, Nguyen JM
    [Addendum concerning: "A prospective trial comparing consecutive series of open retropubic and robot-assisted laparoscopic radical prostatectomy in a centre: Oncologic and functional outcomes" written by J.B. Beauval et al. [Prog. Urol. 25 (2015) 370-
    Prog Urol. 2016;26:383-4.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: